InvestorsHub Logo
Post# of 252445
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 97553

Friday, 07/16/2010 10:07:44 AM

Friday, July 16, 2010 10:07:44 AM

Post# of 252445
Re: Reference links

HIV drugs on market and in development

Merck announced July 14 that it is abandoning development of vicriviroc, the company’s CCR5-blocking HIV entry inhibitor candidate.

http://www.aidsmeds.com/articles/hiv_vicriviroc_merck_1667_18742.shtml

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.